Construction and characterization of a eukaryotic expression vector for small interfering RNA targeting the NEDD9 gene

被引:2
作者
Chang, Jing-Xia [1 ]
Wang, Hua-Qi [1 ]
Zhao, Guo-Qiang [2 ]
Chu, He-Ying [1 ]
Zhang, Guo-Jun [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Resp Med, Zhengzhou, Henan, Peoples R China
[2] Zhengzhou Univ, Dept Microorganisms & Immunizat, Zhengzhou, Henan, Peoples R China
关键词
lung adenocarcinoma; developmentally downregulated 9; RNA interference; A549; cells; PROTEIN; HEF1; METASTASIS; ACTIVATION; RESECTION; DUODENUM; CANCER;
D O I
10.3892/ijmm.2012.1137
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The aim of this study was to construct a eukaryotic expression vector for a small interfering RNA (siRNA) targeting the neural precursor cell expressed, developmentally downregulated 9 (NEDD9) gene, and to investigate the effects of RNA interference (RNAi) on NEDD9 expression in human lung adenocarcinoma A549 cells. We used the siRNA design and analysis software to determine the target oligonucleotides according to the sequence of NEDD9 mRNA available in GenBank. Four siRNA sequences were obtained, and the corresponding cDNAs were synthesized and inserted into the pRNAT-CMV3.2 plasmid to construct the recombinant plasmids. These were transformed into the E. coli strain DH5 alpha. The plasmids, after identification by PCR and DNA sequencing, were transfected into the A549 cell line via the liposome method. NEDD9 mRNA and protein in the cells were determined by fluorescence quantitative RT-PCR (FQ-PCR) and western blotting, respectively. The pRNAT-CMV3.2-transfected plasmid was used as a control. Four recombinant plasmids were identified by PCR and sequence analysis, which contained the correct insertion of the designed sequences in the plasmids. FQ-PCR and western blotting showed substantially decreased mRNA and protein expression of the NEDD9 gene in the transfected cells, compared with the control group. In conclusion, the recombinant plasmids expressing the si RNA targeting the NEDD9 gene were successfully constructed, and the siRNA expression vectors inhibited the expression of NEDD9 in A549 cells.
引用
收藏
页码:1343 / 1348
页数:6
相关论文
共 17 条
  • [1] Chang JX, 2012, MED ONCOL, DOI [10.1007/sl2032-012-0213-0, DOI 10.1007/SI2032-012-0213-0]
  • [2] Deregulation of HEF1 impairs M-phase progression by disrupting the RhoA activation cycle
    Dadke, D
    Jarnik, M
    Pugacheva, EN
    Singh, MK
    Golemis, EA
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2006, 17 (03) : 1204 - 1217
  • [3] Extent of resection in the management of duodenal adenocarcinoma
    Kaklamanos, IG
    Bathe, OF
    Franceschi, D
    Camarda, C
    Levi, J
    Livingstone, AS
    [J]. AMERICAN JOURNAL OF SURGERY, 2000, 179 (01) : 37 - 41
  • [4] Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene
    Kim, Minjung
    Gans, Joseph D.
    Nogueira, Cristina
    Wang, Audrey
    Paik, Ji-Hye
    Feng, Bin
    Brennan, Cameron
    Hahn, William C.
    Cordon-Cardo, Carlos
    Wagner, Stephan N.
    Flotte, Thomas J.
    Duncan, Lyn M.
    Granter, Scott R.
    Chin, Lynda
    [J]. CELL, 2006, 125 (07) : 1269 - 1281
  • [5] Cell cycle-regulated processing of HEF1 to multiple protein forms differentially targeted to multiple subcellular compartments
    Law, SF
    Zhang, YZ
    Klein-Szanto, AJP
    Golemis, EA
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (06) : 3540 - 3551
  • [6] Law SF, 1996, MOL CELL BIOL, V16, P3327
  • [7] LOWELL JA, 1992, ARCH SURG-CHICAGO, V127, P557
  • [8] Structure and function of Cas-L, a 105-kD Crk-associated substrate-related protein that is involved in beta 1 integrin-mediated signaling in lymphocytes
    Minegishi, M
    Tachibana, K
    Sato, T
    Iwata, S
    Nojima, Y
    Morimoto, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) : 1365 - 1375
  • [9] Genes that mediate breast cancer metastasis to lung
    Minn, AJ
    Gupta, GP
    Siegel, PM
    Bos, PD
    Shu, WP
    Giri, DD
    Viale, A
    Olshen, AB
    Gerald, WL
    Massagué, J
    [J]. NATURE, 2005, 436 (7050) : 518 - 524
  • [10] HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells
    Natarajan, M
    Stewart, JE
    Golemis, EA
    Pugacheva, EN
    Alexandropoulos, K
    Cox, BD
    Wang, W
    Grammer, JR
    Gladson, CL
    [J]. ONCOGENE, 2006, 25 (12) : 1721 - 1732